跳至主要内容
临床试验/NCT06500897
NCT06500897已完成不适用

Mid Term Follow up of VEST Device to Enhance Safein Vein Patency: a Multicentric Study

Cardiochirurgia E.H.3 个研究点 分布在 2 个国家目标入组 385 人开始时间: 2017年1月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
385
试验地点
3
主要终点
Re-rivascularization

研究概览

简要总结

Purpose - Bypass grafting is the gold standard for severe coronary disease, yet most repeat revascularizations target previously grafted territories. External stenting of saphenous vein grafts, the most frequently used bypass conduit, has been shown to minimize disease markers. This study evaluates clinical outcomes of external stenting in real world routine practice.

Methods - Three centers enrolled a prospective real-world cohort of external- stenting- enhanced CABG patients. All patients received an internal mammary artery graft to the left anterior descending artery and additional arterial and/or venous grafts. One or more venous grafts were externally stented. Choice of conduits, use of cardiopulmonary bypass, and vein harvesting technique were performed according to the routine practice of each surgeon.

All patients were prescribed standard of care medication and were followed via on site visits or phone interviews for major adverse myocardial and cerebral effects.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • CABG with at least one VEST implant

排除标准

  • 未提供

结局指标

主要结局

Re-rivascularization

时间窗: Up to 7 years

Number of PCI or re-CABG performed, stratified by target site

MACCE

时间窗: Up to 7 years

Major adverse cardiac and cerebrovascular events

次要结局

未报告次要终点

研究者

发起方
Cardiochirurgia E.H.
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

VEST Device to Enhance Safein Vein Patency | 临床试验